Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Composition | 59 | 2024 | 260 | 10.500 |
Why?
|
| Milk, Human | 25 | 2024 | 82 | 7.280 |
Why?
|
| Breast Feeding | 26 | 2024 | 87 | 4.550 |
Why?
|
| Child Development | 14 | 2024 | 71 | 3.950 |
Why?
|
| Plethysmography | 20 | 2020 | 27 | 3.900 |
Why?
|
| Weight Gain | 11 | 2021 | 73 | 2.580 |
Why?
|
| Adipose Tissue | 20 | 2021 | 179 | 2.570 |
Why?
|
| Obesity | 23 | 2022 | 645 | 2.340 |
Why?
|
| Infant | 33 | 2024 | 953 | 2.140 |
Why?
|
| Adiposity | 14 | 2024 | 87 | 2.060 |
Why?
|
| Body Mass Index | 29 | 2022 | 382 | 2.040 |
Why?
|
| Body Weight | 22 | 2019 | 245 | 1.970 |
Why?
|
| Absorptiometry, Photon | 21 | 2020 | 100 | 1.890 |
Why?
|
| Infant Nutritional Physiological Phenomena | 6 | 2021 | 35 | 1.820 |
Why?
|
| Fructose | 5 | 2022 | 22 | 1.820 |
Why?
|
| Female | 83 | 2024 | 14402 | 1.680 |
Why?
|
| Anthropometry | 11 | 2020 | 93 | 1.450 |
Why?
|
| Infant, Newborn | 23 | 2024 | 841 | 1.390 |
Why?
|
| Humans | 102 | 2024 | 26741 | 1.360 |
Why?
|
| Leptin | 7 | 2022 | 66 | 1.340 |
Why?
|
| MicroRNAs | 3 | 2022 | 278 | 1.330 |
Why?
|
| Body Water | 12 | 2016 | 19 | 1.300 |
Why?
|
| Oligosaccharides | 3 | 2023 | 33 | 1.270 |
Why?
|
| Insulin | 7 | 2021 | 309 | 1.190 |
Why?
|
| Male | 63 | 2024 | 12817 | 1.190 |
Why?
|
| Reproducibility of Results | 24 | 2024 | 748 | 1.130 |
Why?
|
| Electric Impedance | 9 | 2020 | 30 | 1.090 |
Why?
|
| Pregnancy | 20 | 2024 | 1126 | 1.090 |
Why?
|
| Diabetes, Gestational | 6 | 2024 | 63 | 1.060 |
Why?
|
| Glucose | 5 | 2021 | 190 | 1.050 |
Why?
|
| Interleukin-6 | 4 | 2021 | 190 | 1.020 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 103 | 0.990 |
Why?
|
| Metabolome | 3 | 2024 | 64 | 0.920 |
Why?
|
| Pediatric Obesity | 4 | 2021 | 70 | 0.910 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 244 | 0.860 |
Why?
|
| Adult | 39 | 2024 | 7350 | 0.850 |
Why?
|
| Exosomes | 2 | 2022 | 86 | 0.840 |
Why?
|
| Adipokines | 3 | 2022 | 9 | 0.800 |
Why?
|
| Carbonated Beverages | 2 | 2018 | 3 | 0.770 |
Why?
|
| Hormones | 2 | 2022 | 41 | 0.760 |
Why?
|
| Lactation | 7 | 2024 | 55 | 0.730 |
Why?
|
| Birth Weight | 5 | 2019 | 63 | 0.710 |
Why?
|
| Body Fluid Compartments | 3 | 2019 | 4 | 0.700 |
Why?
|
| Air | 4 | 2012 | 22 | 0.690 |
Why?
|
| Overweight | 6 | 2017 | 108 | 0.690 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 5 | 2019 | 51 | 0.620 |
Why?
|
| Energy Metabolism | 7 | 2015 | 176 | 0.620 |
Why?
|
| Thiazines | 1 | 2018 | 1 | 0.620 |
Why?
|
| Non-Nutritive Sweeteners | 1 | 2018 | 1 | 0.620 |
Why?
|
| Students | 4 | 2007 | 188 | 0.610 |
Why?
|
| Sucrose | 1 | 2018 | 27 | 0.610 |
Why?
|
| Prospective Studies | 14 | 2024 | 1216 | 0.600 |
Why?
|
| Women's Health | 2 | 2007 | 57 | 0.580 |
Why?
|
| Growth | 2 | 2015 | 24 | 0.560 |
Why?
|
| Mothers | 5 | 2023 | 107 | 0.550 |
Why?
|
| Walking | 2 | 2008 | 130 | 0.540 |
Why?
|
| Athletes | 7 | 2016 | 68 | 0.500 |
Why?
|
| Body Height | 7 | 2018 | 58 | 0.490 |
Why?
|
| Adolescent | 18 | 2016 | 2945 | 0.480 |
Why?
|
| Child | 17 | 2022 | 2134 | 0.480 |
Why?
|
| Diet | 4 | 2019 | 222 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2015 | 120 | 0.450 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 120 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 798 | 0.410 |
Why?
|
| Models, Biological | 7 | 2015 | 446 | 0.400 |
Why?
|
| Cross-Sectional Studies | 11 | 2018 | 908 | 0.400 |
Why?
|
| Martial Arts | 4 | 2012 | 6 | 0.400 |
Why?
|
| Cohort Studies | 8 | 2024 | 857 | 0.400 |
Why?
|
| Aging | 6 | 2015 | 940 | 0.390 |
Why?
|
| Oklahoma | 7 | 2018 | 968 | 0.360 |
Why?
|
| Exercise | 6 | 2015 | 442 | 0.360 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 346 | 0.360 |
Why?
|
| Young Adult | 17 | 2020 | 2573 | 0.360 |
Why?
|
| Monitoring, Physiologic | 2 | 2007 | 54 | 0.360 |
Why?
|
| Reference Values | 6 | 2019 | 197 | 0.340 |
Why?
|
| Dielectric Spectroscopy | 4 | 2012 | 6 | 0.340 |
Why?
|
| Lung Volume Measurements | 2 | 2006 | 3 | 0.340 |
Why?
|
| Gestational Age | 2 | 2019 | 138 | 0.320 |
Why?
|
| Longitudinal Studies | 7 | 2019 | 400 | 0.320 |
Why?
|
| Thorax | 2 | 2007 | 28 | 0.310 |
Why?
|
| Infant Formula | 2 | 2020 | 18 | 0.310 |
Why?
|
| Sex Characteristics | 4 | 2021 | 162 | 0.310 |
Why?
|
| Physical Exertion | 2 | 2008 | 98 | 0.300 |
Why?
|
| Basal Metabolism | 2 | 2006 | 10 | 0.290 |
Why?
|
| Seasons | 1 | 2007 | 82 | 0.290 |
Why?
|
| Adiponectin | 2 | 2019 | 29 | 0.290 |
Why?
|
| Holidays | 1 | 2006 | 4 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 321 | 0.280 |
Why?
|
| Research Design | 2 | 2024 | 173 | 0.280 |
Why?
|
| United States | 7 | 2022 | 2025 | 0.270 |
Why?
|
| Plethysmography, Whole Body | 2 | 2011 | 3 | 0.270 |
Why?
|
| Lipids | 2 | 2022 | 195 | 0.270 |
Why?
|
| Linear Models | 5 | 2015 | 202 | 0.270 |
Why?
|
| Age Factors | 5 | 2015 | 713 | 0.260 |
Why?
|
| Immersion | 1 | 2005 | 4 | 0.260 |
Why?
|
| Universities | 1 | 2006 | 115 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 277 | 0.250 |
Why?
|
| Kynurenine | 1 | 2024 | 21 | 0.240 |
Why?
|
| Postpartum Period | 3 | 2019 | 63 | 0.240 |
Why?
|
| Cytomegalovirus | 1 | 2024 | 21 | 0.240 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 34 | 0.230 |
Why?
|
| Sensitivity and Specificity | 5 | 2016 | 509 | 0.230 |
Why?
|
| Body Fat Distribution | 4 | 2013 | 15 | 0.220 |
Why?
|
| Oxygen Consumption | 6 | 2013 | 173 | 0.220 |
Why?
|
| Sports | 2 | 2016 | 23 | 0.210 |
Why?
|
| Models, Theoretical | 2 | 2013 | 129 | 0.210 |
Why?
|
| Bone Density | 4 | 2022 | 99 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2013 | 93 | 0.200 |
Why?
|
| Motor Activity | 3 | 2013 | 144 | 0.200 |
Why?
|
| Risk Factors | 3 | 2019 | 2008 | 0.200 |
Why?
|
| Sugars | 1 | 2021 | 4 | 0.200 |
Why?
|
| Middle Aged | 11 | 2019 | 6790 | 0.190 |
Why?
|
| Betaine | 1 | 2021 | 4 | 0.190 |
Why?
|
| Research | 3 | 2024 | 87 | 0.190 |
Why?
|
| Oleic Acids | 1 | 2021 | 3 | 0.190 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 13 | 0.190 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2020 | 4 | 0.190 |
Why?
|
| Child, Preschool | 5 | 2020 | 1081 | 0.190 |
Why?
|
| Weight Loss | 2 | 2015 | 71 | 0.180 |
Why?
|
| Infant Health | 1 | 2020 | 2 | 0.180 |
Why?
|
| Body Weights and Measures | 1 | 2020 | 17 | 0.180 |
Why?
|
| Water | 2 | 2015 | 131 | 0.180 |
Why?
|
| Clothing | 1 | 2000 | 4 | 0.180 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 578 | 0.170 |
Why?
|
| Area Under Curve | 2 | 2018 | 93 | 0.170 |
Why?
|
| Cytokines | 1 | 2022 | 437 | 0.170 |
Why?
|
| Indicator Dilution Techniques | 3 | 2016 | 7 | 0.160 |
Why?
|
| High Fructose Corn Syrup | 1 | 2018 | 1 | 0.160 |
Why?
|
| Isotopes | 2 | 2012 | 9 | 0.150 |
Why?
|
| Infant, Premature | 1 | 2019 | 133 | 0.150 |
Why?
|
| Random Allocation | 2 | 2015 | 148 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 980 | 0.150 |
Why?
|
| Cognition | 1 | 2020 | 294 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 93 | 0.140 |
Why?
|
| Radioisotope Dilution Technique | 2 | 2009 | 14 | 0.140 |
Why?
|
| Whey Proteins | 1 | 2015 | 11 | 0.130 |
Why?
|
| Muscle Contraction | 1 | 1997 | 161 | 0.130 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 21 | 0.130 |
Why?
|
| Nursing Homes | 2 | 1994 | 43 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2015 | 34 | 0.130 |
Why?
|
| Models, Statistical | 2 | 2013 | 118 | 0.130 |
Why?
|
| Pericardium | 1 | 2015 | 47 | 0.130 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 6 | 0.130 |
Why?
|
| Echocardiography | 1 | 2015 | 107 | 0.130 |
Why?
|
| Risk | 1 | 2015 | 133 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2013 | 472 | 0.130 |
Why?
|
| Human Development | 1 | 2015 | 4 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2015 | 28 | 0.120 |
Why?
|
| Postprandial Period | 2 | 2019 | 41 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2019 | 300 | 0.120 |
Why?
|
| Basal Ganglia Diseases | 1 | 1994 | 3 | 0.120 |
Why?
|
| Rest | 1 | 2015 | 90 | 0.120 |
Why?
|
| Antipsychotic Agents | 1 | 1994 | 24 | 0.120 |
Why?
|
| Regression Analysis | 3 | 2005 | 209 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 912 | 0.110 |
Why?
|
| Skinfold Thickness | 2 | 2013 | 19 | 0.110 |
Why?
|
| Accelerometry | 1 | 2013 | 11 | 0.110 |
Why?
|
| Heart Rate | 2 | 2013 | 374 | 0.110 |
Why?
|
| Indians, North American | 2 | 2015 | 505 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2011 | 351 | 0.110 |
Why?
|
| Aged | 7 | 2007 | 5152 | 0.110 |
Why?
|
| Torso | 1 | 2013 | 5 | 0.110 |
Why?
|
| Muscle Strength | 2 | 2011 | 214 | 0.100 |
Why?
|
| Drug Utilization | 1 | 1992 | 28 | 0.100 |
Why?
|
| Deuterium | 4 | 2016 | 50 | 0.100 |
Why?
|
| Psychotropic Drugs | 1 | 1992 | 8 | 0.100 |
Why?
|
| Bloodletting | 1 | 1992 | 2 | 0.100 |
Why?
|
| Pulse | 1 | 1992 | 4 | 0.100 |
Why?
|
| Posture | 1 | 1992 | 39 | 0.100 |
Why?
|
| Bias | 1 | 2012 | 38 | 0.100 |
Why?
|
| African Americans | 3 | 2006 | 348 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 95 | 0.100 |
Why?
|
| Sex Factors | 2 | 2013 | 443 | 0.100 |
Why?
|
| Forearm | 1 | 2011 | 36 | 0.100 |
Why?
|
| Portugal | 2 | 2012 | 2 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 388 | 0.090 |
Why?
|
| Radial Artery | 1 | 2011 | 21 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2010 | 12 | 0.090 |
Why?
|
| Software | 1 | 2012 | 121 | 0.090 |
Why?
|
| Algorithms | 2 | 2006 | 419 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 385 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 57 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 618 | 0.090 |
Why?
|
| Term Birth | 1 | 2009 | 10 | 0.080 |
Why?
|
| Bromides | 3 | 2016 | 5 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2007 | 8 | 0.080 |
Why?
|
| Fetal Blood | 2 | 2022 | 37 | 0.080 |
Why?
|
| Functional Residual Capacity | 2 | 2006 | 2 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 36 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 116 | 0.080 |
Why?
|
| Mass Media | 1 | 2008 | 8 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2008 | 95 | 0.080 |
Why?
|
| Midwestern United States | 1 | 2007 | 38 | 0.080 |
Why?
|
| Thinness | 2 | 2007 | 16 | 0.070 |
Why?
|
| Massachusetts | 2 | 2021 | 16 | 0.070 |
Why?
|
| Gases | 1 | 2007 | 23 | 0.070 |
Why?
|
| Calorimetry, Indirect | 1 | 2006 | 14 | 0.070 |
Why?
|
| Physical Education and Training | 1 | 2007 | 45 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 8 | 0.070 |
Why?
|
| Health Status | 1 | 2007 | 145 | 0.070 |
Why?
|
| Alabama | 1 | 2006 | 4 | 0.070 |
Why?
|
| Body Surface Area | 1 | 2006 | 7 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 100 | 0.070 |
Why?
|
| Health Promotion | 1 | 2008 | 160 | 0.070 |
Why?
|
| Italy | 2 | 2019 | 13 | 0.070 |
Why?
|
| Hydrostatic Pressure | 1 | 2005 | 3 | 0.070 |
Why?
|
| Tidal Volume | 1 | 2004 | 6 | 0.060 |
Why?
|
| Writing | 1 | 2024 | 14 | 0.060 |
Why?
|
| Science | 1 | 2024 | 17 | 0.060 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 4 | 0.060 |
Why?
|
| Mentors | 1 | 2024 | 31 | 0.060 |
Why?
|
| Research Report | 1 | 2024 | 22 | 0.060 |
Why?
|
| Narration | 1 | 2024 | 20 | 0.060 |
Why?
|
| Metabolism | 1 | 2004 | 9 | 0.060 |
Why?
|
| Infusion Pumps | 1 | 2004 | 3 | 0.060 |
Why?
|
| Syringes | 1 | 2004 | 6 | 0.060 |
Why?
|
| Publishing | 1 | 2024 | 30 | 0.060 |
Why?
|
| Viral Load | 1 | 2024 | 31 | 0.060 |
Why?
|
| Tryptophan | 1 | 2024 | 38 | 0.060 |
Why?
|
| Ethics, Research | 1 | 2024 | 36 | 0.060 |
Why?
|
| Feces | 1 | 2024 | 107 | 0.060 |
Why?
|
| Physical Fitness | 2 | 2000 | 61 | 0.060 |
Why?
|
| Homes for the Aged | 2 | 1994 | 7 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2003 | 86 | 0.050 |
Why?
|
| C-Peptide | 1 | 2022 | 8 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 198 | 0.050 |
Why?
|
| Oxytocin | 1 | 2021 | 5 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2021 | 87 | 0.050 |
Why?
|
| Hair | 1 | 2001 | 15 | 0.050 |
Why?
|
| Eating | 1 | 2021 | 66 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 175 | 0.050 |
Why?
|
| Densitometry | 1 | 2000 | 9 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 1564 | 0.050 |
Why?
|
| Weight Lifting | 1 | 2000 | 46 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 11 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 130 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2020 | 28 | 0.040 |
Why?
|
| Ireland | 1 | 2019 | 8 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 177 | 0.040 |
Why?
|
| Breast Milk Expression | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lactose | 1 | 2018 | 5 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 758 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 124 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 166 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2018 | 73 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2015 | 2426 | 0.040 |
Why?
|
| Ergometry | 1 | 1997 | 7 | 0.040 |
Why?
|
| Acceleration | 1 | 1997 | 16 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 1997 | 21 | 0.040 |
Why?
|
| Arm | 1 | 1997 | 35 | 0.040 |
Why?
|
| Motor Skills | 1 | 1997 | 32 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 1997 | 72 | 0.030 |
Why?
|
| Exercise Test | 3 | 2003 | 246 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 12 | 0.030 |
Why?
|
| Leg | 1 | 1997 | 131 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2016 | 25 | 0.030 |
Why?
|
| Fetal Weight | 1 | 2015 | 8 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 18 | 0.030 |
Why?
|
| Glycated Hemoglobin A | 1 | 2015 | 64 | 0.030 |
Why?
|
| Animals | 2 | 2021 | 9918 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 53 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 398 | 0.030 |
Why?
|
| Family | 1 | 2015 | 98 | 0.030 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1994 | 2 | 0.030 |
Why?
|
| Parkinson Disease, Secondary | 1 | 1994 | 2 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 383 | 0.030 |
Why?
|
| Adolescent Development | 1 | 2013 | 8 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 469 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 357 | 0.030 |
Why?
|
| Logistic Models | 1 | 1994 | 397 | 0.030 |
Why?
|
| Geriatric Psychiatry | 1 | 1992 | 1 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 1994 | 237 | 0.030 |
Why?
|
| Education, Nursing, Continuing | 1 | 1992 | 7 | 0.030 |
Why?
|
| Education, Continuing | 1 | 1992 | 11 | 0.030 |
Why?
|
| Mental Processes | 1 | 1992 | 16 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 1992 | 10 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 76 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 1992 | 28 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 1992 | 29 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1992 | 34 | 0.030 |
Why?
|
| Blood Donors | 1 | 1992 | 4 | 0.030 |
Why?
|
| Diastole | 1 | 1992 | 22 | 0.030 |
Why?
|
| Systole | 1 | 1992 | 24 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 16 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2011 | 3 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2011 | 11 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 4389 | 0.020 |
Why?
|
| Hand Strength | 1 | 2011 | 33 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 156 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 250 | 0.020 |
Why?
|
| Compliance | 1 | 2011 | 21 | 0.020 |
Why?
|
| Puberty | 1 | 2011 | 13 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 263 | 0.020 |
Why?
|
| Sodium Compounds | 1 | 2010 | 2 | 0.020 |
Why?
|
| Body Size | 1 | 2009 | 30 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 1924 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 698 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2007 | 10 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1992 | 2262 | 0.020 |
Why?
|
| Glycerol | 1 | 2004 | 16 | 0.010 |
Why?
|
| Epinephrine | 1 | 2003 | 36 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 748 | 0.010 |
Why?
|
| Scalp | 1 | 2001 | 13 | 0.010 |
Why?
|
| Face | 1 | 2001 | 25 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2000 | 77 | 0.010 |
Why?
|